Search Results - "Masleša-Galić S"

Evolutionary trends of plague research from 2016 to 2025: A bibliometric analysis.

Authors: Niu, Yanfen Zhang, Yihui Zhou, Song et al.

Source: PLoS Neglected Tropical Diseases. 5/13/2026, Vol. 20 Issue 5, p1-16. 16p.

Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.

Authors: Jia Q Bielefeldt-Ohmann H Maison RM et al.

Source: Microbiology spectrum [Microbiol Spectr] 2023 Apr 13; Vol. 11 (2), pp. e0503522. Date of Electronic Publication: 2023 Mar 14.

Publication Type: Journal Article

Journal Info: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE; PubMed not MEDLINE

Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.

Authors: Gröhn S Lehto H Soppela S et al.

Source: BMC infectious diseases [BMC Infect Dis] 2026 Jan 29; Vol. 26 (1). Date of Electronic Publication: 2026 Jan 29.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE; In Process

Bioengineered bacteria in cancer immunotherapy: mechanistic advances, therapeutic strategies and clinical potential.

Authors: Vadakkan K Karippali S Jacob J et al.

Source: Archives of microbiology [Arch Microbiol] 2026 Jun 24; Vol. 208 (9). Date of Electronic Publication: 2026 Jun 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0410427 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-072X (Electronic) Linking ISSN: 03028933 NLM ISO Abbreviation: Arch Microbiol Subsets: MEDLINE; In Process

Advances in clinical trial design: Weaving tomorrow's TB treatments.

Authors: Lienhardt, Christian Nunn, Andrew Chaisson, Richard et al.

Source: PLoS Medicine. 2/27/2020, Vol. 17 Issue 2, p1-12. 12p. 2 Charts.

Plague vaccines: new developments in an ongoing search.

Authors: Rosenzweig, Jason A. Hendrix, Emily K. Chopra, Ashok K.

Source: Applied Microbiology & Biotechnology; Jun2021, Vol. 105 Issue 12, p4931-4941, 11p

Developing Next‐Generation Protein‐Based Vaccines Using High‐Affinity Glycan Ligand‐Decorated Glyconanoparticles.

Authors: Gao, Yanan Wang, Wei Yang, Yunru et al.

Source: Advanced Science. Jan2023, Vol. 10 Issue 2, p1-16. 16p.

Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time.

Authors: Lee BY Clemens DL Silva A et al.

Source: Nature communications [Nat Commun] 2017 Jan 24; Vol. 8, pp. 14183. Date of Electronic Publication: 2017 Jan 24.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.

Authors: Khlebnikova, Alina Kirshina, Anna Zakharova, Natalia et al.

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13139. 35p.

Immunogenicity of culture filtrated proteins and whole-cell killed formalin of Listeria monocytogenes to induced cellular immune response in vivo.

Authors: Al-Bayati, Hassan H. K. Abdullah, Sultan Ahmed Shihab, Thamer Jaddoa et al.

Source: Open Veterinary Journal. 2024, Vol. 14 Issue 12, p3581-3598. 18p.

Development of a diagnostic compatible BCG vaccine against Bovine tuberculosis.

Authors: Chandran, Aneesh Williams, Kerstin Mendum, Tom et al.

Source: Scientific Reports. 11/28/2019, Vol. 9 Issue 1, p1-11. 11p.

Botanical Compounds: A Promising Approach to Control Mycobacterium Species of Veterinary and Zoonotic Importance.

Authors: Aljohani, Abdullah S. M.¹ jhny@qu.edu.sa

Source: Pakistan Veterinary Journal. 2023, Vol. 43 Issue 4, p633-642. 10p.

Recent Advancements and Novel Approaches Contributing to the Present Arsenal of Prophylaxis and Treatment Strategies Against Category A Bacterial Biothreat Agents.

Authors: Patnaik, Abhinandan Rai, Sharad Kumar Dhaked, Ram Kumar

Source: Indian Journal of Microbiology. Jun2023, Vol. 63 Issue 2, p161-172. 12p.

Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.

Authors: Liang, Fengyi¹ (AUTHOR) antlfy@nus.edu.sg

Source: Viruses (1999-4915). May2023, Vol. 15 Issue 5, p1193. 19p.

Whole-genome sequencing analysis of two heat-evolved Escherichia coli strains.

Authors: McGuire, Bailey E. Nano, Francis E.

Source: BMC Genomics. 3/27/2023, Vol. 24 Issue 1, p1-19. 19p.

Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19.

Authors: Yakoubi, Afef Dhafer, Cyrine El Baher

Source: Plasmonics. Feb2023, Vol. 18 Issue 1, p311-347. 37p.

Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors.

Authors: Lim, Jhin Jieh Hooi, Lissa Dan, Yock Young et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 8/15/2022, Vol. 41 Issue 1, p1-21. 21p.

Ergothioneine, Ovothiol A, and Selenoneine—Histidine-Derived, Biologically Significant, Trace Global Alkaloids.

Authors: Cordell, Geoffrey A. Lamahewage, Sujeewa N. S.

Source: Molecules. May2022, Vol. 27 Issue 9, p2673-2673. 24p.

Hacking Commensal Bacteria to Consolidate the Adaptive Mucosal Immune Response in the Gut–Lung Axis: Future Possibilities for SARS-CoV-2 Protection.

Authors: Pereira, Marcela Oh, Ju Kyoung Kang, Dae-Kyung et al.

Source: BioTech. Mar2022, Vol. 11 Issue 1, p3. 18p.

Correction: Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs.

Source: PLoS ONE. 5/30/2019, Vol. 14 Issue 5, p1-3. 3p.